Prothena Dirección
Dirección controles de criterios 3/4
El CEO de Prothena's es Gene Kinney , nombrado en Sep 2016, tiene una permanencia de 7.58 años. compensación anual total es $7.04M, compuesta por 9% salario y 91% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.024% de las acciones de la empresa, por valor de $262.98K. La antigüedad media del equipo directivo y de la junta directiva es de 7.1 años y 7.6 años, respectivamente.
Información clave
Gene Kinney
Chief Executive Officer (CEO)
US$7.0m
Compensación total
Porcentaje del salario del CEO | 9.0% |
Permanencia del CEO | 7.7yrs |
Participación del CEO | 0.02% |
Permanencia media de la dirección | 7.2yrs |
Promedio de permanencia en la Junta Directiva | 7.7yrs |
Actualizaciones recientes de la dirección
Recent updates
Prothena: Alzheimer's Data Update In 2024 Could Move The Needle
Feb 23Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%
Feb 08Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?
Dec 20Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business
Nov 24Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk
Oct 27Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Aug 25What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today
May 10We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth
Apr 23Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook
Mar 01We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate
Dec 28Prothena: Paying A Premium To Cover All The Alzheimer's Bases
Sep 29Prothena GAAP EPS of -$0.88 misses by $0.31
Aug 08Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates
May 08Are Prothena Corporation plc (NASDAQ:PRTA) Investors Paying Above The Intrinsic Value?
Jan 10Prothena: A Biotech Company With A Promising Pipeline
Dec 01Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Dec 31 2023 | US$7m | US$631k | -US$147m |
Sep 30 2023 | n/a | n/a | -US$73m |
Jun 30 2023 | n/a | n/a | -US$141m |
Mar 31 2023 | n/a | n/a | -US$128m |
Dec 31 2022 | US$7m | US$601k | -US$117m |
Sep 30 2022 | n/a | n/a | -US$156m |
Jun 30 2022 | n/a | n/a | -US$1m |
Mar 31 2022 | n/a | n/a | US$67m |
Dec 31 2021 | US$5m | US$573k | US$67m |
Sep 30 2021 | n/a | n/a | US$69m |
Jun 30 2021 | n/a | n/a | -US$70m |
Mar 31 2021 | n/a | n/a | -US$124m |
Dec 31 2020 | US$3m | US$554k | -US$111m |
Sep 30 2020 | n/a | n/a | -US$102m |
Jun 30 2020 | n/a | n/a | -US$91m |
Mar 31 2020 | n/a | n/a | -US$80m |
Dec 31 2019 | US$3m | US$538k | -US$78m |
Sep 30 2019 | n/a | n/a | -US$79m |
Jun 30 2019 | n/a | n/a | -US$84m |
Mar 31 2019 | n/a | n/a | -US$128m |
Dec 31 2018 | US$11m | US$525k | -US$156m |
Sep 30 2018 | n/a | n/a | -US$181m |
Jun 30 2018 | n/a | n/a | -US$209m |
Mar 31 2018 | n/a | n/a | -US$167m |
Dec 31 2017 | US$5m | US$521k | -US$153m |
Compensación vs. Mercado: La compensación total ($USD7.04M) de Gene está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD5.67M).
Compensación vs. Ingresos: La compensación de Gene ha aumentado mientras la empresa no es rentable.
CEO
Gene Kinney (54 yo)
7.7yrs
Permanencia
US$7,043,826
Compensación
Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 7.7yrs | US$7.04m | 0.024% $ 293.3k | |
CFO & Chief Strategy Officer | 11.2yrs | US$2.70m | 0.0060% $ 73.4k | |
Chief Operating Officer | 2.6yrs | US$2.63m | 0% $ 0 | |
Chief Regulatory Officer | 7.4yrs | US$2.57m | 0% $ 0 | |
Chief Medical Officer | 3.1yrs | US$2.68m | 0% $ 0 | |
Chief Accounting Officer & Controller | 11yrs | sin datos | sin datos | |
Chief Scientific Officer | 6.9yrs | US$3.34m | sin datos | |
Vice President of Investor Relations | no data | sin datos | sin datos | |
Chief Legal Officer | no data | US$1.18m | sin datos | |
Chief People Officer | less than a year | sin datos | sin datos | |
Company Secretary | no data | sin datos | sin datos |
7.2yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de PRTA es experimentado (7.1 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 7.7yrs | US$7.04m | 0.024% $ 293.3k | |
Independent Director | 1.8yrs | US$896.63k | 0% $ 0 | |
Independent Director | 11.4yrs | US$912.48k | 0.0023% $ 28.0k | |
Independent Director | less than a year | sin datos | sin datos | |
Independent Chairman | 19yrs | US$923.48k | 0.00045% $ 5.5k | |
Independent Director | 11.4yrs | US$354.39k | 0% $ 0 | |
Independent Director | 10.8yrs | US$901.73k | 0.0078% $ 96.5k | |
Independent Director | 9.3yrs | US$907.48k | 0% $ 0 | |
Independent Director | 4.8yrs | US$908.48k | 0% $ 0 | |
Independent Director | 4.4yrs | sin datos | sin datos | |
Independent Director | less than a year | US$1.70m | sin datos |
7.7yrs
Permanencia media
63yo
Promedio de edad
Junta con experiencia: La junta directiva de PRTA se considera experimentada (7.6 años de antigüedad promedio).